Anna De Rosa

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study

Ruth Chia, Sara Sáez-Atiénzar, Natalie A. Murphy et al. · Proceedings of the National Academy of Sciences · 2022 · 132 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients

Inga Koneczny, Jo Stevens, Anna De Rosa et al. · Journal of Autoimmunity · 2016 · 129 citations · Full text

Life Sciences, Biochemistry, Immunology +17

IgG-specific cell-based assay detects potentially pathogenic MuSK-Abs in seronegative MG

Saif Huda, Patrick Waters, Mark Woodhall et al. · Neurology Neuroimmunology & Neuroinflammation · 2017 · 73 citations · Full text

Life Sciences, Immunology, Pathology +7

Incidence and Long-term Functional Outcome of Neurologic Disorders in Hospitalized Patients With COVID-19 Infected With Pre-Omicron Variants

Simone Beretta, Viviana Cristillo, Giorgia Camera et al. · Neurology · 2023 · 36 citations · Full text

Medicine, Infectious Diseases, Neurology +14